Nokea
Patients who are on long-term aspirin therapy should have ____ annually.
- A. Complete blood count
- B. Salicylate level
- C. Amylase
- D. Urine analysis
Correct Answer: A
Rationale: Annual CBC monitors for aspirin-related bleeding; salicylate isn't routine yearly.
You may also like to solve these questions
Patients with iron deficiency will develop:
- A. Hemolytic anemia
- B. Megaloblastic anemia
- C. Macrocytic-hypochromic anemia
- D. Microcytic-hypochromic anemia
Correct Answer: D
Rationale: Iron deficiency causes microcytic-hypochromic anemia due to reduced hemoglobin synthesis.
The nurse is applying a topical corticosteroid to a client with eczema. The nurse would monitor for the potential for increased systemic absorption of the medication if the medication were being applied to which of the following body areas?
- A. Back
- B. Axilla
- C. Soles of the feet
- D. Palms of the hands
Correct Answer: B
Rationale: Topical corticosteroids can be absorbed into the systemic circulation. Absorption is higher from regions where the skin is especially permeable (scalp, axilla, face, eyelids, neck, perineum, genitalia), and lower from regions in which permeability is poor (back, palms, soles).
Theophylline levels in blood are increased by:
- A. Erythromycin
- B. Ciprofloxacin
- C. Smoking
- D. Digitalis
Correct Answer: A
Rationale: Erythromycin inhibits theophylline metabolism, raising levels.
After administering a medication, for what would the nurse assess the patient?
- A. Drug effects
- B. Allergies
- C. Pregnancy
- D. Preexisting conditions
Correct Answer: A
Rationale: After the medication is administered, the nurse assesses the patient for drug affects, both therapeutic and adverse. The nurse would assess the patient for allergies, preexisting conditions, and pregnancy before administering a medication.
Reduce the likelihood of therapeutic failure with tamoxifen treatment
- A. Not provided in document
- B. Not provided in document
- C. Not provided in document
- D. Not provided in document
Correct Answer: B
Rationale: This question lacks options, but the answer key (ANS: 2) suggests the second choice. Strategies to reduce therapeutic failure include avoiding CYP2D6 inhibitors to ensure proper metabolism of tamoxifen to its active form.